News

Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor Cardiologists were urged to halt the "epidemic of madness" behind drug-eluting stent (DES) overuse, during an address by Salim Yusuf, M.D., McMaster University, Hamilton, Ontario, at the World Congress of Cardiology in Barcelona.

Home September 18, 2006
Home
News

Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent System were presented at the World Congress of Cardiology conference in Barcelona, Spain. XIENCE V, which has received CE Mark approval, is currently an investigational device in the U.S. and Japan — Abbott says it plans to initiate European launch of the coronary DES in October.

Home September 18, 2006
Home
News

Thousands of lives potentially saved and hospital costs reduced are the predicted outcomes if more hospitals adopt certain quality measures on a wider scale, according to an analysis by Premier Inc. healthcare alliance, headquartered in San Diego, which is owned by more than 200 of the nation's leading not-for-profit hospitals and healthcare systems.

Home September 18, 2006
Home
Feature | Ryan Hiett

It may seem like a simple concept, but the importance of properly controlled patient temperature is still surprising ...

Home September 12, 2006
Home
Feature | Mark Paquin

The long-standing standard of care for patients with carotid artery disease was surgery and/or medical management. In August 2004, the U.S. Food and Drug Administration changed all that when it approved the first carotid stenting system, called the RX ACCULINK Carotid Artery Stent System and RX ACCUNET Embolic Protection System by Guidant.

Home August 29, 2006
Home
Technology

Abiomed Inc. recently announced the start of the IMPELLA 2.5 pilot study in the U.S. with the enrollment of the first ...

Home August 29, 2006
Home
Technology

A software fusion application that enables clinicians to perform multimodality image fusion in a single application ...

Home August 29, 2006
Home
Technology

OXILAN (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reportedly ...

Home August 29, 2006
Home
Feature

Frustrated over healthcare's “failure” to deter the growth of cardiac disease while holding many valuable, predictive ...

Home August 29, 2006
Home
Feature | Kim Phelan

Dead is dead — everyone knows it, especially physicians. And what’s dead can’t be recovered; or can it? Startling ...

Home August 29, 2006
Home
Technology

The Relay 250-mm thoracic stent-graft is commercially available in Europe in both straight and taper configurations. The ...

Home August 29, 2006
Home
Technology

The EXCOR TAH-t has received CE approval with the CardioWest TAH-t. The pneumatic drivers provide precisely calibrated ...

Home August 29, 2006
Home
Technology

The Philips integrated cath lab is a solution featuring integrated technologies designed to improve productivity and throughput.

Home August 29, 2006
Home
Case Study

Situated in America’s heartland, St. Elizabeth Regional Medical Center is a healthcare leader for metro Lincoln, NE. It has been rated one of the Top 100 Hospitals by Solucient two of the past three years and recognized as a Magnet hospital by the American Nurses Credentialing Center for excellence in nursing.

Home August 29, 2006
Home
Technology

The Atlas II ICD (implantable cardioverter defibrillator) and Atlas II HF CRT-D (cardiac resynchronization therapy defibrillator) devices are capable of delivering unsurpassed energy, giving added security to patients whose hearts are especially difficult to defibrillate.

Home August 29, 2006
Home
Subscribe Now